These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 35128693)
1. Long-term immunity in convalescent Syrian hamsters provides protection against new-variant SARS-CoV-2 infection of the lower but not upper respiratory tract. Stauft CB; Selvaraj P; Lien CZ; Starost MF; Wang TT J Med Virol; 2022 Jun; 94(6):2833-2836. PubMed ID: 35128693 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract. Hansen F; Meade-White K; Clancy C; Rosenke R; Okumura A; Hawman DW; Feldmann F; Kaza B; Jarvis MA; Rosenke K; Feldmann H Cell Rep; 2022 Mar; 38(11):110515. PubMed ID: 35263638 [TBL] [Abstract][Full Text] [Related]
4. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters. Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002 [TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern. Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters. Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339 [TBL] [Abstract][Full Text] [Related]
7. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model. Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747 [TBL] [Abstract][Full Text] [Related]
8. Nasal Mucosa Exploited by SARS-CoV-2 for Replicating and Shedding during Reinfection. Li H; Zhao X; Li J; Zheng H; Zhao Y; Yang J; Zhou J; Yang F; Chen Y; Zuo Y; Lai Q; Long H; Li Y; Jin W; Shi H; Liu L Viruses; 2022 Jul; 14(8):. PubMed ID: 35893674 [TBL] [Abstract][Full Text] [Related]
9. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters. Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a new SARS-CoV-2 variant that emerged in Brazil. Imai M; Halfmann PJ; Yamayoshi S; Iwatsuki-Horimoto K; Chiba S; Watanabe T; Nakajima N; Ito M; Kuroda M; Kiso M; Maemura T; Takahashi K; Loeber S; Hatta M; Koga M; Nagai H; Yamamoto S; Saito M; Adachi E; Akasaka O; Nakamura M; Nakachi I; Ogura T; Baba R; Fujita K; Ochi J; Mitamura K; Kato H; Nakajima H; Yagi K; Hattori SI; Maeda K; Suzuki T; Miyazato Y; Valdez R; Gherasim C; Furusawa Y; Okuda M; Ujie M; Lopes TJS; Yasuhara A; Ueki H; Sakai-Tagawa Y; Eisfeld AJ; Baczenas JJ; Baker DA; O'Connor SL; O'Connor DH; Fukushi S; Fujimoto T; Kuroda Y; Gordon A; Maeda K; Ohmagari N; Sugaya N; Yotsuyanagi H; Mitsuya H; Suzuki T; Kawaoka Y Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34140350 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters. Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735 [TBL] [Abstract][Full Text] [Related]
13. Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters. King HAD; Dussupt V; Mendez-Rivera L; Slike BM; Tran U; Jackson ND; Barkei E; Zemil M; Tourtellott-Fogt E; Kuklis CH; Soman S; Ahmed A; Porto M; Kitajewski C; Spence B; Benetiene D; Wieczorek L; Kar S; Gromowski G; Polonis VR; Krebs SJ; Modjarrad K; Bolton DL Front Immunol; 2023; 14():1138629. PubMed ID: 37026013 [TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. Roberts A; Vogel L; Guarner J; Hayes N; Murphy B; Zaki S; Subbarao K J Virol; 2005 Jan; 79(1):503-11. PubMed ID: 15596843 [TBL] [Abstract][Full Text] [Related]
15. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera. Espeseth AS; Yuan M; Citron M; Reiserova L; Morrow G; Wilson A; Horton M; Rukhman M; Kinek K; Hou F; Li SL; Li F; Choi Y; Heidecker G; Luo B; Wu G; Zhang L; Strable E; DeStefano J; Secore S; Mukhopadhyay TK; Richardson DD; Sayeed E; Welch LS; Bett AJ; Feinberg MB; Gupta SB; Cooper CL; Parks CL EBioMedicine; 2022 Aug; 82():104203. PubMed ID: 35915046 [TBL] [Abstract][Full Text] [Related]
16. Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model. Johnson S; Martinez CI; Tedjakusuma SN; Peinovich N; Dora EG; Birch SM; Kajon AE; Werts AD; Tucker SN J Infect Dis; 2022 Jan; 225(1):34-41. PubMed ID: 34758086 [TBL] [Abstract][Full Text] [Related]
17. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2. Braxton AM; Creisher PS; Ruiz-Bedoya CA; Mulka KR; Dhakal S; Ordonez AA; Beck SE; Jain SK; Villano JS Comp Med; 2021 Oct; 71(5):398-410. PubMed ID: 34588095 [TBL] [Abstract][Full Text] [Related]
18. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19. Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection. Nuñez IA; Lien CZ; Selvaraj P; Stauft CB; Liu S; Starost MF; Wang TT mSphere; 2021 Jun; 6(3):e0050721. PubMed ID: 34133199 [TBL] [Abstract][Full Text] [Related]
20. Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant. Ryan KA; Bewley KR; Watson RJ; Burton C; Carnell O; Cavell BE; Challis A; Coombes NS; Davies ER; Edun-Huges J; Emery K; Fell R; Fotheringham SA; Gooch KE; Gowan K; Handley A; Harris DJ; Hesp R; Hunter L; Humphreys R; Johnson R; Kennard C; Knott D; Lister S; Morley D; Ngabo D; Osman KL; Paterson J; Penn EJ; Pullan ST; Richards KS; Summers S; Thomas SR; Weldon T; Wiblin NR; Rayner EL; Vipond RT; Hallis B; Salguero FJ; Funnell SGP; Hall Y PLoS Pathog; 2023 Apr; 19(4):e1011293. PubMed ID: 37014911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]